drugset / Trial / NCT00191178

Effects of Insulin in Perceived Mood Symptoms in Patients With Type 2 Diabetes

NCT00191178

Phase 4 Completed 60 enrolled Eli Lilly and Company
RandomizedCrossoverOpen-labelTreatment

Summary

This study investigates the influence of two different insulin regimens, twice-daily insulin lispro low mix (LM) and once-daily insulin glargine, on perceived physical, mood, and cognitive symptoms as well as cognitive-motor task performance in patients with type 2 diabetes.

Timeline

Start
2003-08
Primary completion
Completion
2005-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Lispro Protein / enzyme biologic
Subject insulin glargine Protein / enzyme biologic